Immugen Pharmaceuticals
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7900 SW 57th Ave, South Miami, Florida, ...Phone Number
(305) 666-4093Website
www.immugen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Immugen Pharmaceuticals
Immugen BioPharma, Inc. is focused on developing non-hormonal treatments for women's health, specifically targeting the genitourinary syndrome of menopause (GSM). The company aims to obtain FDA approval for its lead compound, a non-psychoactive derivative of THC. Their innovative approach harnesses the endocannabinoid system to provide transformative solutions for women experiencing menopause. Immugen BioPharma is dedicated to improving the quality of life for women through advanced therapeutic options.Explore more
Immugen Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immugen Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Immugen Pharmaceuticals had a recent Job posting/layoffs
Check out if Immugen Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Immugen Pharmaceuticals recently announced quarterly report
Check if Immugen Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Immugen Pharmaceuticals
Immugen Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Immugen Pharmaceuticals has new funding data
Product Launch: Get notified when Immugen Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Immugen Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Immugen Pharmaceuticals
Compare insights from companies similar to Immugen Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Immugen Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Immugen Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Immugen Pharmaceuticals.
Immugen Pharmaceuticals financials insights
Gather financial insights about Immugen Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1996
Unspecified
$759K
Immugen Pharmaceuticals Tech Stack
A closer look at the technologies used by Immugen Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immugen Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Immugen BioPharma, Inc. is focused on developing non-hormonal treatments for women's health, specifically targeting the genitourinary syndrome of menopause (GSM). The company aims to obtain FDA approval for its lead compound, a non-psychoactive derivative of THC. Their innovative approach harnesses the endocannabinoid system to provide transformati... Read More
